Cargando…

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial (123)I-MIBG turnover can identify Lewy body disease

BACKGROUND: Using two static scans for (123)I-meta-iodobenzyl-guanidine ((123)I-MIBG) myocardial scintigraphy ignores the dynamic response from vesicular trapping in nerve terminals. Moreover, the long pause between scans is impractical for patients with Lewy body diseases (LBDs). Here, we optimized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumakura, Yoshitaka, Shimizu, Yuji, Hariu, Masatsugu, Ichikawa, Ken-ichi, Yoshida, Norihito, Suzuki, Masato, Oji, Satoru, Narukawa, Shinya, Yoshimasu, Haruo, Nomura, Kyoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671580/ https://www.ncbi.nlm.nih.gov/pubmed/34905123 http://dx.doi.org/10.1186/s13550-021-00864-w

Ejemplares similares

Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure
por: Veltman, Caroline E., et al.
Publicado: (2012)

Diagnosis of dementia with Lewy bodies: diagnostic performance of combined (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy
por: Sakamoto, Fumi, et al.
Publicado: (2013)

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015)

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

Potential Utility of (123)I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
por: Murakami, Nagahisa, et al.
Publicado: (2019)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2012)

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice
por: Skowronek, Cornelia, et al.
Publicado: (2019)

Transformation of a nonfunctional paraganglioma with I-123 MIBG scintigraphy correlation: A case report: Notice of Retraction
Publicado: (2016)

Bilateral adrenal uptake of (123)I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
por: Inaba, Yuiko, et al.
Publicado: (2022)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio
por: Dimitriu-Leen, Aukelien C., et al.
Publicado: (2015)

Influence of antidepressant use on (123)I-MIBG heart and lung uptakes in the diagnosis of Lewy body disease
por: Adaniya, Shinobu, et al.
Publicado: (2022)

Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease
por: ASAHI, Takashi, et al.
Publicado: (2016)

(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
por: Lewington, V., et al.
Publicado: (2016)

The relation between cardiac (123)I-mIBG scintigraphy and functional response 1 year after CRT implantation
por: Verschure, D O, et al.
Publicado: (2020)

Can early phase cardiac [(123)I]mIBG images be used to diagnose Lewy body disease?
por: Roberts, Gemma, et al.
Publicado: (2022)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Vascular time-activity variation in patients undergoing (123)I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
por: Verberne, Hein J., et al.
Publicado: (2011)

Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG Myocardial Scintigraphy Study
por: Villacorta, Aline Sterque, et al.
Publicado: (2016)

Author Correction: Bilateral adrenal uptake of (123)I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
por: Inaba, Yuiko, et al.
Publicado: (2022)

Utility of (123)I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
por: Wakabayashi, Hiroshi, et al.
Publicado: (2019)

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease
por: Spiegel, Jörg
Publicado: (2009)

Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis
por: Slaets, Sylvie, et al.
Publicado: (2015)

Myocardial (123)I-MIBG Uptake and Cardiovascular Autonomic Function in Parkinson's Disease
por: Katagiri, Akira, et al.
Publicado: (2015)

Cardiac sympathetic activity in chronic heart failure: cardiac (123)I-mIBG scintigraphy to improve patient selection for ICD implantation
por: Verschure, D. O., et al.
Publicado: (2016)

Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [(123)I]MIBG heart scintigraphy
por: Lindberg, Lotte, et al.
Publicado: (2021)

Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017)

Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
por: Sato, Kenichiro, et al.
Publicado: (2016)

Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
por: Chequer, Renata, et al.
Publicado: (2015)

(123)I-MIBG Scintigraphy as a Powerful Tool to Plan an Implantable Cardioverter Defibrillator and to Assess Cardiac Resynchronization Therapy in Heart Failure Patients
por: Stefanelli, Antonella, et al.
Publicado: (2012)

Myocardial (123)I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

Diagnostic Accuracy of (123)I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study
por: Yoshita, Mitsuhiro, et al.
Publicado: (2015)

Montreal Cognitive Assessment Predicts the Short‐Term Risk of Lewy Body Disease in Isolated REM Sleep Behavior Disorder with Reduced MIBG Scintigraphy
por: Miyamoto, Masayuki, et al.
Publicado: (2022)

(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
por: Chung, Eun Joo, et al.
Publicado: (2015)

Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022)

Cardiac (123)I-mIBG Imaging in Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2022)

123-Iodine MIBG in the Assessment of Sympathetic Denervation in Ogilvie's Syndrome
por: Bhoil, Amit, et al.
Publicado: (2022)

Polymorphism of SLC6A2 gene does not influence outcome of myocardial (123)I-mIBG scintigraphy in patients with chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e828e56h7qgp5rr07bp5b9c9s2